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Abstract The role of innate and adaptive immune cells in the
experimental model of nephrotoxic serum nephritis (NTS) has
been rigorously studied in recent years. The model is depen-
dent on kidney-infiltrating T helper (TH) 17 and TH1 cells,
which recruit neutrophils and macrophages, respectively, and
cause sustained kidney inflammation. In a later phase of dis-
ease, regulatory T cells (Tregs) infiltrate the kidney in an at-
tempt to limit disease activity. In the early stage of NTS,
lymph node drainage plays an important role in disease initi-
ation since dendritic cells present the antigen to Tcells in the T
cell zones of the draining lymph nodes. This results in the
differentiation and proliferation of TH17 and TH1 cells. In
this setting, immune regulatory cells (Tregs), namely, CCR7-
expressing Tregs and mast cells (MCs), which are recruited by
Tregs via the production of interleukin-9, exert their immuno-
suppressive capacity. Together, these two cell populations in-
hibit T cell differentiation and proliferation, thereby limiting
disease activity by as yet unknown mechanisms. In contrast,
the spleen plays no role in immune activation in NTS, but
constitutes a place of extramedullary haematopoiesis. The
complex interactions of immune cells in NTS are still under
investigation and might ultimately lead to targeted therapies in
glomerulonephritis.
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Innate and adaptive immune cells in the kidney
in nephrotoxic serum nephritis
The nephrotoxic serum nephritis (NTS) model is a mouse
model which is commonly used to study a type of immune
complex-mediated, rapidly progressive glomerulonephritis
(GN). It is induced by the injection of antibodies raised either
in rabbits or sheep that are directed against the glomerular
basement membrane (GBM). In the model used in our labo-
ratory, a subcutaneous immunization against rabbit immuno-
globulin G (IgG) prior to injection of the antiserum is needed
to induce rapid-progressive GN within 7 to 14 days [1–3].
Other research groups using sheep anti-GBM antibody have
reported that the immunization step is not required to induce a
form of rapid-progressive GN [4, 5]. The so-called autologous
phase of disease is characterized by nephrotic range albumin-
uria, a proliferative form of GN with crescent formation as
well as infiltration of immune cells into the kidney [3]. The
pathogenesis has been shown to be dependent on innate and
adaptive immune cells as well as on the complement system.
Kurts and coworkers recently published an excellent summary
of the time course of kidney-infiltrating immune cells in NTS
[6]. Gamma delta (γδ) T cells are the first cells to find their
way into the kidney, attracting neutrophil granulocytes via the
cytokine interleukin (IL)-17 [7]. Neutrophils, recruited via C-
X-C motif chemokine ligand 1 (CXCL-1) [8], immediately
infiltrate the kidney, mainly the glomeruli where they cause
damage to glomerular cells. The absence of γδ T cells has
been proven to protect mice from NTS [2]. Next, T helper
(TH) 17 cells expressing CC chemokine receptor (CCR) 6
infiltrate the renal interstitium and glomeruli and in turn re-
cruit neutrophils which infiltrate mainly the interstitium [9].
The recruitment of these neutrophils has been proven to be
dependent on CXCL-5 rather than CXCL-1. CXCL-5 is in-
duced in renal tubular epithelial cells by TH17 cells [8]. The
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prolonged infiltration of these adaptive immune cells seems to
be dependent on dendritic cells (DCs) expressing CX3CR1
and CCR2 [10]. The latter also recruit TH1 cells, which lead
to the infiltration of macrophages by the secretion of
interferon-γ [11]. Depletion of either TH17 or TH1 cells sig-
nificantly ameliorates the NTS phenotype in mice [5, 12].
DCs also recruit and activate effector T cells in the kidney
by activation of the inflammasome and subsequent production
of IL-1β and IL-18 [13]. In addition, activation of the
inflammasome in macrophages by the P2X7 receptor in-
creases disease activity [14].
Interestingly, not only pro-inflammatory cells infil-
trate the kidney in NTS, but also regulatory immune
cells which limit the on-going pro-inflammatory pro-
cesses. In the early phase of disease, immature DCs
recruit CCR6, expressing invariant natural killer T
(iNKT) cells via the secretion of CXCL16 [15]. iNKT
cells also have regulatory properties and suppress early
infiltrating TH17 cells via the cytokines IL-4 and IL-10
[15]. TH17-specific STAT3-positive Tregs have recently
been shown to infiltrate the kidney in the early phase of
NTS and limit TH17 cell activation [16]. In the later
phase of disease, regulatory T cells (Tregs) also infil-
trate the kidney and limit TH1 activation by IL-10 se-
cretion [6, 17, 18]. In early studies conducted in our
laboratory, we did not detect early infiltration of Tregs
into the kidneys [3, 19], but only infiltration in the
prolonged phase of disease (Eller et al., unpublished
observation). This difference might be explained by
the different anti-GBM antibodies used as well as the
need for immunization in our model.
Of note, the complement system activated by the IgG de-
posited in the glomeruli is also involved in the pathogenesis of
NTS, especially in the model of accelerated NTS which needs
pre-immunization against IgG. In the majority of studies, in-
hibition of the complement pathways resulted in an improve-
ment of accelerated NTS [20–22]. In contrast, C1q deficien-
cy—an early step of activation of the classical complement
pathway—results in accelerated NTS disease activity proba-
bly due to a defect in the clearance of immune complexes and/
or apoptotic cells from glomeruli [23].
Thus, both pro- and anti-inflammatory cell populations,
including innate and adaptive immune cells, infiltrate the kid-
ney during the course of NTS. Nevertheless, essential early
immune regulation in NTS takes place in the secondary lym-
phoid organs, especially in draining lymph nodes. This is de-
scribed in the following sections of this review.
Immune regulation in the draining lymph node
The importance of the lymph node in the pathogenesis of NTS
first became evident when CD4+CD25+ Tregs were found to
limit disease activity when transferred into mice prior to NTS
induction. Interestingly, Tregs were not detectable in the kid-
ney, but rather in secondary lymphoid organs and here mainly
in the lymph nodes [19]. Evaluation of the role of CCR7
further contributed to a better understanding of the migration
of Tregs in NTS. CCR7 is expressed not only on Tregs, but
also on T cells and DCs [24]. By binding to their cognate CC
chemokine ligands (CCL)-19 and -21, T cells and DCs are
guided to the T cell zone of the lymph node, where DCs can
present the antigen to T cells, which thereafter differentiate
into effector T cells [24]. We have reported that CCR7
knock-out mice were more susceptible to NTS than controls
due to a significant lower number of Tregs in the draining
lymph nodes [3]. Interestingly, in our study the majority of
Tregs were detected in the kidneys of CCR7 knock-out mice,
but here they lost their ability to inhibit disease activity [3].
Thus, in the early phase of NTS, the correct localization of
Tregs to the draining lymph nodes is paramount to an effective
inhibition of disease progression.
MCs have also been shown to regulate NTS activity,
mainly in the draining lymph node. MCs are known as
main effector cells in allergic disease, but in recent
years it has become evident that they have additional
important roles in regulating the adaptive immune re-
sponse by influencing the migration, proliferation and
activation of B cells, T cells and DCs [25]. In the NTS
model as well as in an anti-neutrophil cytoplasmic an-
tibody (ANCA) vasculitis model, MCs have been
found to inhibit the progression of kidney disease
[26–28]. Interestingly, in a previous study we found
that only a few MCs were present in the kidney, and
those which were present were mainly located in the
capsule; these MCs did not increase in number when
NTS was induced [27]. In a subsequent study, we
found that MCs were present in the draining lymph
nodes and that they significantly increased in number
during the course of NTS, mainly due to increased
migration to the lymph node [29]. Targeting MCs by
stabilizing agents has recently proven to limit ANCA
vasculitis activity in the kidney in an experimental mu-
rine model and therefore makes the MC population an
interesting new therapeutic target in GN [30].
Based on observations in skin transplant experiments
[31], Lu and colleagues speculated that Tregs and MCs
might interact with each other, also in NTS, and to-
gether inhibit disease activation in the draining lymph
node. We proved that Tregs recruit MCs to the
draining lymph node in the NTS model through Treg-
derived cytokine IL-9 and that together these two cell
populations form a microenvironment that inhibits ef-
fector T cells [29]. How MCs exert their anti-
inflammatory capacity in NTS is still a focus of on-
going research.
Pediatr Nephrol
Role of the spleen in NTS
It was long unclear whether the spleen plays a similar role as
the draining lymph node in NTS. Since Tregs increased and
homed not only to the draining lymph node but also to the
spleen [3, 19], there was indirect evidence that the spleen
might be of crucial importance in the immune regulation in
NTS. Furthermore, spleen size and weight increased signifi-
cantly during the course of NTS [32]. Data on the functional
role of the spleen in human patients with GN are scarce. Case
reports provide anecdotal evidence of a potential beneficial,
but also harmful effect of splenectomy in patients with GN
due to cryoglobulinaemia, IgA nephritis and connective tissue
disease [33–35].
In a recent publication, splenectomized mice displayed
comparable disease indices as sham-operated mice after
NTS induction, indicating that the spleen has no direct role
in the pathogenesis of NTS. Interestingly, significant differ-
ences in the haemoglobin levels were detected in
splenectomized mice as compared to sham-operated controls.
Obviously the increase in spleen size is mainly due to
extramedullary haematopoiesis, which partly steps in for the
significantly decreased haematopoiesis in the bone marrow
observed in NTS [32].
Proposed model of immune regulation in NTS
Based on the data of our group and other research groups, we
propose the following model of immune regulation in NTS
(Fig. 1). Two compartments are mainly involved in the im-
mune regulation in NTS, namely, the draining lymph node
and the kidney. We propose that DCs take up the antigen in
the kidney and then migrate to the draining lymph node,
where they present the antigen to T cells. To date, this mech-
anism has been proven for a tubular autoantigen [36], an en-
dogenous kidney antigen, the Tamm–Horsfall protein [37],
small molecular weight antigens that pass the glomerular filter
[38] and a glomerular model autoantigen transgenically
expressed in podocytes [39]. We propose that the migration
of DCs to the draining lymph node in NTS is CCR7–CCL19/
21 dependent, but we have also detected CCR7–CCL19/21-
independent DC migration in NTS (Eller et al. unpublished
data). In the draining lymph node, the antigen is presented to T
Fig. 1 Proposed model of immune regulations in of nephrotoxic serum nephritis. Ag Antigen, CCL CC chemokine ligands, CCR CC chemokine
receptor, DC dendritic cells, IL interleukin, MCs mast cells, TH T helper cells, Treg regulatory T cells
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cells, which differentiate and proliferate to effector TH
cells. In NTS, TH1 and TH17 cells mediate disease
activity [5, 12]. Both cell populations find their way
into the kidney by the use of chemokine gradients as
summarized by Kurts and coworkers [6]. The first TH
cells entering the kidney in NTS are TH17 cells, which
mainly recruit neutrophil granulocytes to the kidney via
CXCL-5 [8]. Later in the course of the disease, TH1
cells migrate to the kidney and recruit macrophages.
The inflammation is perpetuated by intrarenal DCs ex-
pressing CX3 chemokine receptor 1 (CX3CR-1) which
process the antigen and keep stimulating effector T cells
in the kidney [40] by inflammasome-dependent cyto-
kines such as IL-1β [13]. Regulation of the immune
response during the early phase takes place in the
draining lymph node and is mediated by CCR7-
expressing Treg cells, which effectively inhibit the dif-
ferentiation and expansion of effector TH cells [3, 19].
This mechanism is partly mediated by a Treg-dependent
recruitment of MCs to the draining lymph node via
secretion of IL-9 and CXCL-1 [29]. How MCs exert
their immunosuppressive capacities in the lymph node
in NTS remains unclear at present. During the course
of disease, Tregs also migrate to the kidney in an at-
tempt to limit renal inflammation. It has been shown
that both TH17-specific Tregs and CCR6-expressing
Tregs are recruited to the kidney to limit intrarenal in-
flammation in NTS [9, 16–18].
Conclusions
In recent past years different research groups have rigorously
evaluated the various mechanisms of immune regulation and
the migration of immune cells in the NTS model. Pro- and
anti-inflammatory regulations interact closely in different
compartments, namely, the draining lymph node and the kid-
ney. Nevertheless, several questions in immune regulation re-
main unresolved, which argues for further research in the field
to pave the way for targeted immune therapies of rapid pro-
gressive GN.
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